HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
Shutting down myeloma growth by changing the soil where it grows with Dr. Noopur Raje of Massachusetts General Hospital Cancer Center
Shutting down myeloma growth by changing the soil where it grows with Dr. Noopur Raje of Massachusetts General Hospital Cancer Center image
HealthTree Podcast for Multiple Myeloma
event Jan 17, 2014 / 11:00AM - 12:00PM MST

Event Description

Dr. Noopur Raje, MD
Massachusetts Cancer Center and Raje Lab

Interview date: January 17, 2014

Myeloma cells can't survive outside of the bone marrow. Dr. Noopur Raje, MD, of Massachusetts General Cancer Center tells us that the "soil" in which they are growing is an important target for new treatments. Dr. Raje describes her work to make the bone marrow neighborhood as unfriendly as possible to stop the growth of myeloma cells. She describes how current myeloma drugs can change the bone marrow environment: Proteasome inhibitors  boost new bone growth while the IMiDs  boost immunity and bump up natural killer cells. She then expands the capacity of those drugs using a new HDAC inhibitor called ACY-1215 with existing myeloma drugs. In one study, Velcade blocks the protein pathway while the HDAC inhibitor blocks another pathway and prevents the cells from becoming Velcade-resistant. She uses another example of combining this same new drug with  IMiDs to affect a commonly mutated gene called C-Myc. She describes a trial for older patients using a standard triple combination that can be modified for age by lowering the dosage (RVD Lite). She regularly performs genetic testing as part of her standard care and is looking to target specific genes, using the BRAF and MEK genes as examples. Her research suggests that treating the bone marrow environment can also help to heal bone lesions. Dr. Raje reminds us that the 9 new myeloma drugs in the last 10 years came about because patients participated in myeloma trials. She notes that when patients wait to join a clinical trial when they are out of options, it is not really helpful, and encourages patients to take advantage of early access to therapies that go beyond the standard of care. 

The live mPatient Myeloma Radio podcast with Dr. Noopur Raje

Schedule & Agenda

Dr Noopur Raje & Jenny Ahlstrom

Speakers & Moderators

The panelist Noopur Raje, MD
Noopur Raje, MD

Noopur Raje, MD, is director of the Center for Multiple Myeloma at Massachusetts General Hospital. She is also Associate Professor of Medicine at Harvard Medical School. Her primary focus is treating patients with multiple myeloma and related plasma cell disorders. Dr. Raje leads a dedicated clinical team engaged in investigator-initiated, multi-center national and international clinical trials, all aimed at developing new promising therapies for multiple myeloma. Her laboratory efforts are focused on identifying cellular signaling pathways that contribute to the survival and proliferation of myeloma cells in the bone environment for which targeting may result in improved therapeutic outcomes.

Read Bio
The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us


+1 800 709 1113


Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube